ABL1_MOUSE - dbPTM
ABL1_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ABL1_MOUSE
UniProt AC P00520
Protein Name Tyrosine-protein kinase ABL1
Gene Name Abl1
Organism Mus musculus (Mouse).
Sequence Length 1123
Subcellular Localization Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. The myristoylated c-ABL protein is reported to be nuclear. Sequestered into the cytoplasm through interaction with 14-3-3 proteins (By similarity). Localizes to mitochondria in response to oxidative st
Protein Description Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (By similarity). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-191' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. Regulates T-cell differentiation in a TBX21-dependent manner. [PubMed: 21690296 Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity]
Protein Sequence MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGTRGGAGSMLQAPELPTKTRTCRRAAEQKDAPDTPELLHTKGLGESDALDSEPAVSPLLPRKERGPPDGSLNEDERLLPRDRKTNLFSALIKKKKKMAPTPPKRSSSFREMDGQPDRRGASEDDSRELCNGPPALTSDAAEPTKSPKASNGAGVPNGAFREPGNSGFRSPHMWKKSSTLTGSRLAAAEEESGMSSSKRFLRSCSASCMPHGARDTEWRSVTLPRDLPSAGKQFDSSTFGGHKSEKPALPRKRTSESRSEQVAKSTAMPPPRLVKKNEEAAEEGFKDTESSPGSSPPSLTPKLLRRQVTASPSSGLSHKEEATKGSASGMGTPATAEPAPPSNKVGLSKASSEEMRVRRHKHSSESPGRDKGRLAKLKPAPPPPPACTGKAGKPAQSPSQEAGEAGGPTKTKCTSLAMDAVNTDPTKAGPPGEGLRKPVPPSVPKPQSTAKPPGTPTSPVSTPSTAPAPSPLAGDQQPSSAAFIPLISTRVSLRKTRQPPERIASGTITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLESNLRELQICPATASSGPAATQDFSKLLSSVKEISDIVRR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 4)Myristoylation-10.1212654251
16 (in isoform 4)Phosphorylation-34.2326824392
43PhosphorylationDFEPQGLSEAARWNS
CCCCCCHHHHHHHCC
31.8226643407
50PhosphorylationSEAARWNSKENLLAG
HHHHHHCCCCCCCCC
34.0926824392
70PhosphorylationPNLFVALYDFVASGD
CCCEEEEEEHHHCCC
9.52-
93PhosphorylationEKLRVLGYNHNGEWC
CEEEEEEECCCCCEE
14.7547733
115PhosphorylationQGWVPSNYITPVNSL
CCCCCCCCCCCCHHH
15.5423069
128PhosphorylationSLEKHSWYHGPVSRN
HHCCCCCCCCCCCCH
10.4261675
139PhosphorylationVSRNAAEYLLSSGIN
CCCHHHHHHHHCCCC
14.2848383
172PhosphorylationLRYEGRVYHYRINTA
EEECCEEEEEEEEEC
7.5665559
174PhosphorylationYEGRVYHYRINTASD
ECCEEEEEEEEECCC
8.7665711
178PhosphorylationVYHYRINTASDGKLY
EEEEEEEECCCCCEE
25.7624453211
180PhosphorylationHYRINTASDGKLYVS
EEEEEECCCCCEEEC
44.8729514104
185PhosphorylationTASDGKLYVSSESRF
ECCCCCEEECCHHHH
11.1912522270
187O-linked_GlycosylationSDGKLYVSSESRFNT
CCCCEEECCHHHHHH
18.1630059200
215PhosphorylationGLITTLHYPAPKRNK
CCEEECCCCCCCCCC
12.28-
226PhosphorylationKRNKPTIYGVSPNYD
CCCCCCEEEECCCCC
17.6012522270
229PhosphorylationKPTIYGVSPNYDKWE
CCCEEEECCCCCCCC
11.76-
232PhosphorylationIYGVSPNYDKWEMER
EEEECCCCCCCCEEC
23.4523075
253PhosphorylationHKLGGGQYGEVYEGV
ECCCCCCCCEEECCH
20.6623077
257PhosphorylationGGQYGEVYEGVWKKY
CCCCCEEECCHHHHE
11.5823023260
264PhosphorylationYEGVWKKYSLTVAVK
ECCHHHHEEEEEEEE
12.7512522270
389PhosphorylationFGLSRLMTGDTYTAH
HCCCHHCCCCCEECC
36.1822499769
392PhosphorylationSRLMTGDTYTAHAGA
CHHCCCCCEECCCCC
24.9022499769
393PhosphorylationRLMTGDTYTAHAGAK
HHCCCCCEECCCCCC
13.4825521595
394PhosphorylationLMTGDTYTAHAGAKF
HCCCCCEECCCCCCC
17.6612522270
413PhosphorylationTAPESLAYNKFSIKS
CCCHHHHCCCCCCCC
24.9547737
446PhosphorylationPYPGIDLSQVYELLE
CCCCCCHHHHHHHHH
17.539109492
469PhosphorylationEGCPEKVYELMRACW
CCCCHHHHHHHHHHH
17.8912522270
547PhosphorylationEQKDAPDTPELLHTK
HHCCCCCCHHHHCCC
20.011956339
553PhosphorylationDTPELLHTKGLGESD
CCHHHHCCCCCCCCC
27.1228066266
559PhosphorylationHTKGLGESDALDSEP
CCCCCCCCCCCCCCC
26.78-
564PhosphorylationGESDALDSEPAVSPL
CCCCCCCCCCCCCCC
46.4523984901
569PhosphorylationLDSEPAVSPLLPRKE
CCCCCCCCCCCCCHH
16.3727087446
618PhosphorylationAPTPPKRSSSFREMD
CCCCCCCCCCHHHCC
36.1430635358
619PhosphorylationPTPPKRSSSFREMDG
CCCCCCCCCHHHCCC
37.2129899451
620PhosphorylationTPPKRSSSFREMDGQ
CCCCCCCCHHHCCCC
29.578548467
656PhosphorylationTSDAAEPTKSPKASN
CCCCCCCCCCCCCCC
35.3430482847
658PhosphorylationDAAEPTKSPKASNGA
CCCCCCCCCCCCCCC
33.8327149854
682PhosphorylationPGNSGFRSPHMWKKS
CCCCCCCCCCCCCCC
19.52-
689PhosphorylationSPHMWKKSSTLTGSR
CCCCCCCCCCCCHHH
25.4829514104
690PhosphorylationPHMWKKSSTLTGSRL
CCCCCCCCCCCHHHH
35.9927600695
693PhosphorylationWKKSSTLTGSRLAAA
CCCCCCCCHHHHHHH
32.9528576409
710AcetylationESGMSSSKRFLRSCS
HHCCCHHHHHHHHCC
49.47-
715PhosphorylationSSKRFLRSCSASCMP
HHHHHHHHCCCCCCC
17.9925521595
717PhosphorylationKRFLRSCSASCMPHG
HHHHHHCCCCCCCCC
25.1825266776
719PhosphorylationFLRSCSASCMPHGAR
HHHHCCCCCCCCCCC
8.4826643407
734PhosphorylationDTEWRSVTLPRDLPS
CCCCEEEECCCCCCC
32.0927149854
750PhosphorylationGKQFDSSTFGGHKSE
CCCCCCCCCCCCCCC
30.1929514104
769PhosphorylationPRKRTSESRSEQVAK
CCCCCCCCHHHHHHH
40.65-
800PhosphorylationAEEGFKDTESSPGSS
HHHCCCCCCCCCCCC
38.0525619855
802PhosphorylationEGFKDTESSPGSSPP
HCCCCCCCCCCCCCC
43.8825619855
803PhosphorylationGFKDTESSPGSSPPS
CCCCCCCCCCCCCCC
27.3525619855
806PhosphorylationDTESSPGSSPPSLTP
CCCCCCCCCCCCCCH
42.9525619855
807PhosphorylationTESSPGSSPPSLTPK
CCCCCCCCCCCCCHH
46.9025521595
810PhosphorylationSPGSSPPSLTPKLLR
CCCCCCCCCCHHHHH
48.5425619855
812PhosphorylationGSSPPSLTPKLLRRQ
CCCCCCCCHHHHHHH
23.7925619855
821PhosphorylationKLLRRQVTASPSSGL
HHHHHHCCCCCCCCC
17.0629514104
823PhosphorylationLRRQVTASPSSGLSH
HHHHCCCCCCCCCCC
18.8929472430
825PhosphorylationRQVTASPSSGLSHKE
HHCCCCCCCCCCCHH
34.2529472430
844PhosphorylationGSASGMGTPATAEPA
CCCCCCCCCCCCCCC
10.80-
902AcetylationPPPACTGKAGKPAQS
CCCCCCCCCCCCCCC
35.4921781306
909PhosphorylationKAGKPAQSPSQEAGE
CCCCCCCCCCCCCHH
28.7325521595
911PhosphorylationGKPAQSPSQEAGEAG
CCCCCCCCCCCHHCC
45.9930635358
970PhosphorylationKPPGTPTSPVSTPST
CCCCCCCCCCCCCCC
25.22-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
226YPhosphorylationKinaseABL1P00520
GPS
393YPhosphorylationKinaseABL1P00520
PhosphoELM
393YPhosphorylationKinaseHCKP08631
PSP
393YPhosphorylationKinaseHCKP08103
PSP
393YPhosphorylationKinaseABL-FAMILY-GPS
393YPhosphorylationKinaseSRC-TYPE TYR-KINASES-Uniprot
547TPhosphorylationKinaseCDK1P11440
PSP
547TPhosphorylationKinaseCDK-FAMILY-GPS
547TPhosphorylationKinaseCDK_GROUP-PhosphoELM
569SPhosphorylationKinaseCDK1P11440
PSP
569SPhosphorylationKinaseCDK-FAMILY-GPS
569SPhosphorylationKinaseCDK_GROUP-PhosphoELM
618SPhosphorylationKinasePAK2Q8CIN4
Uniprot
619SPhosphorylationKinasePAK2Q8CIN4
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
2GMyristoylation

12654251
446SPhosphorylation

9109492
547TPhosphorylation

2183353
569SPhosphorylation

2183353
618SPhosphorylation

12748290
619SPhosphorylation

12748290
710KAcetylation

-
734TPhosphorylation

12748290

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ABL1_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RIN1_MOUSERin1physical
9144171
PAXI_MOUSEPxnphysical
9603926
ABL1_MOUSEAbl1physical
11274764
PTN11_MOUSEPtpn11physical
9393882
CBL_MOUSECblphysical
9393882
CRKL_MOUSECrklphysical
8978305
CBL_MOUSECblphysical
10391678
CBL_MOUSECblphysical
8635998
SHIP1_MOUSEInpp5dphysical
11031258
DOK1_MOUSEDok1physical
10823839
PPARG_MOUSEPpargphysical
25368164

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ABL1_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Functional interaction between DNA-PK and c-Abl in response to DNAdamage.";
Kharbanda S., Pandey P., Jin S., Inoue S., Bharti A., Yuan Z.-M.,Weichselbaum R., Weaver D., Kufe D.;
Nature 386:732-735(1997).
Cited for: FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, PHOSPHORYLATION ATSER-446, AND MUTAGENESIS OF SER-446.
"Differential phosphorylation of c-Abl in cell cycle determined bycdc2 kinase and phosphatase activity.";
Kipreos E.T., Wang J.Y.;
Science 248:217-220(1990).
Cited for: PHOSPHORYLATION AT THR-547 AND SER-569.
"Structural mechanism for STI-571 inhibition of Abelson tyrosinekinase.";
Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B.,Kuriyan J.;
Science 289:1938-1942(2000).
Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 229-515 IN COMPLEX WITHINHIBITOR STI-571, CATALYTIC ACTIVITY, ENZYME REGULATION,PHOSPHORYLATION AT TYR-393, AND ACTIVATION LOOP.
"Two distinct phosphorylation pathways have additive effects on Ablfamily kinase activation.";
Tanis K.Q., Veach D., Duewel H.S., Bornmann W.G., Koleske A.J.;
Mol. Cell. Biol. 23:3884-3896(2003).
Cited for: FUNCTION, ENZYME REGULATION, INTERACTION WITH CRK, AUTOPHOSPHORYLATIONAT TYR-226 AND TYR-393, AND MUTAGENESIS OF TYR-226; LYS-271 ANDTYR-393.

TOP